Controlled Ovarian Stimulation After Fertility-Sparing Surgery for Borderline Ovarian Tumors: An Exploratory Cohort Study on Recurrence and Reproductive Outcomes
Authors:
- Sofia ThiellaSTSofia Thiella
- Giacomo CorradoGiacomo Corrado
- Paola VillaPVPaola Villa
- Inge PetersInge Peters
- Diana GiannarelliDGDiana Giannarelli
- Rossella Letizia MancusiRMRossella Letizia Mancusi
- Tina PasciutoTina Pasciuto
- Lucrezia MassaroLMLucrezia Massaro
- Maria Luisa Di PietroMPMaria Luisa Di Pietro
- Maria Lucia SpecchiaMSMaria Lucia Specchia
- Anna FagottiAFAnna Fagotti
Open Access
- 3 April 2026
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 33 (4) , 206
Abstract
Borderline ovarian tumors often affect women of reproductive age for whom fertility preservation may be a major concern. While fertility-sparing surgery is widely accepted, the safety of controlled ovarian stimulation for oocyte cryopreservation after surgery remains uncertain due to potential recurrence risk. This retrospective single-center cohort study explored the association between controlled ovarian stimulation following fertility-sparing surgery and both recurrence risk and reproductive outcomes. Patients treated between January 2011 and June 2024 were included. Baseline characteristics, surgical details, and reproductive outcomes were compared using non-parametric and exact tests. Progression-free survival was assessed with Kaplan–Meier estimates and Cox proportional hazards models, modeling stimulation as a time-dependent covariate, and using a 10-month landmark analysis to account for immortal time bias. Of 45 included patients, 19 underwent ovarian stimulation after surgery, with a median interval of 9.9 months to stimulation. Median follow-up was 34.4 months. Recurrence occurred in 21.1% of stimulated patients versus 38.5% of non-stimulated patients (p = 0.338). After adjustment for time-dependent exposure, ovarian stimulation was not associated with increased recurrence risk (HR 0.95, 95% CI 0.22–4.09; p = 0.944). Eleven patients (24.4%) achieved at least one pregnancy, 81.8% of which were spontaneous. Controlled ovarian stimulation for oocyte cryopreservation after fertility-sparing surgery for borderline ovarian tumors did not show an increased recurrence risk, although larger studies are needed.Keywords
This publication has 24 references indexed in Scilit:
- Fertility preservation through oocyte or embryo vitrification prior to oncological treatment: a 12-year experienceJournal of Assisted Reproduction and Genetics, 2025
- An umbrella review of meta-analyses regarding the incidence of female-specific malignancies after fertility treatmentFertility and Sterility, 2024
- Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGEThe Lancet Oncology, 2024
- Reproductive outcomes in women opting for fertility preservation after fertility-sparing surgery for borderline ovarian tumorsArchives of Gynecology and Obstetrics, 2024
- Does controlled ovarian hyperstimulation in women with a history of borderline tumor influence recurrence rate?Archives of Gynecology and Obstetrics, 2023
- Fertility preservation in women with malignant and borderline ovarian tumors: Experience of the French ESGO-certified center and pregnancy-associated cancer network (CALG)Gynecologic Oncology, 2021
- Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. An analysis from the MITO14 study databaseGynecologic Oncology, 2021
- Risk factors for recurrence of borderline ovarian tumors in France: A multicenter retrospective study by the FRANCOGYN groupJournal of Gynecology Obstetrics and Human Reproduction, 2021
- Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkersJournal of Gynecology Obstetrics and Human Reproduction, 2021
- What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcomeEuropean Journal of Surgical Oncology, 2020